GAF Healthcare
Specialty Overview

Best Hospitals for Stem Cell Therapy in Dubai, UAE

3 hematology hospitals in our UAE network are listed in Dubai, accredited by Hospital Certificates of Services, JCI, with 423 beds combined.

3
Hospitals Listed
1
City
4.5
Avg. Rating
2
Accreditation Types
The Short Answer

This page lists the hematology hospitals in our directory offering Stem Cell Therapy in Dubai, UAE, including Burjeel Hospital for Advanced Surgery Dubai, Kings College Hospital Dubai, Aster Hospital Dubai. Each listing links through to the hospital's full profile page.

Including:🇦🇪 Burjeel Hospital for Advanced Surgery Dubai🇦🇪 Kings College Hospital Dubai🇦🇪 Aster Hospital Dubai

Ask us about stem cell therapy in Dubai, UAE

Share a few details and our care coordination team will get back to you with next steps.

Top Hospitals for Stem Cell Therapy in Dubai, UAE

Burjeel Hospital for Advanced Surgery Dubai Featured

🇦🇪 Burjeel Hospital for Advanced Surgery Dubai

Dubai, UAE 4.5 (1 reviews) 209 beds
Why consider this hospital?
4.5/5 rating from 1 reviews209 beds
Specialties & Accreditation
OrthopedicsCardiac SciencesCosmetic SurgeryGastroenterologyGeneral SurgeryGynecologyStem Cell Therapy
Hospit — Hospital Certificates of Services accreditation
View full profile →

Patients considering stem cell therapy can be cared for by Burjeel Hospital for Advanced Surgery Dubai's care team in Dubai, UAE, from initial consultation through recovery. Burjeel Hospital for Advanced Surgery Dubai, accredited by Hospital Certificates of Services, follows recognised patient-safety and quality-of-care standards when performing stem cell therapy.

4.5/5
Rating
2014
Established
209
Beds
Dubai, UAE
Location
Enquire NowView Profile
Kings College Hospital Dubai

🇦🇪 Kings College Hospital Dubai

Dubai, UAE 4.5 (1 reviews) 100 beds
Why consider this hospital?
4.5/5 rating from 1 reviews100 beds
Specialties & Accreditation
Cardiac SciencesCosmetic SurgeryENTGastroenterologyGeneral SurgeryGynecologyStem Cell Therapy
Hospit — Hospital Certificates of Services accreditation
View full profile →

Patients considering stem cell therapy can be cared for by Kings College Hospital Dubai's care team in Dubai, UAE, from initial consultation through recovery. Kings College Hospital Dubai, accredited by Hospital Certificates of Services, follows recognised patient-safety and quality-of-care standards when performing stem cell therapy.

4.5/5
Rating
2014
Established
100
Beds
Dubai, UAE
Location
Enquire NowView Profile
Aster Hospital Dubai

🇦🇪 Aster Hospital Dubai

Dubai, UAE 4.5 (1 reviews) 114 beds
Why consider this hospital?
4.5/5 rating from 1 reviews114 beds
Specialties & Accreditation
BariatricCardiac SciencesCosmetic SurgeryENTGastroenterologyGeneral SurgeryStem Cell Therapy
JCI — Joint Commission International accreditation
View full profile →

Patients considering stem cell therapy can be cared for by Aster Hospital Dubai's care team in Dubai, UAE, from initial consultation through recovery. Aster Hospital Dubai, accredited by JCI, follows recognised patient-safety and quality-of-care standards when performing stem cell therapy.

4.5/5
Rating
1987
Established
114
Beds
Dubai, UAE
Location
Enquire NowView Profile
Our Methodology

How we selected these hospitals

A hospital appears on this page when Hematology is among its listed specialties and it is located in Dubai, UAE. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Stem Cell Therapy in Dubai, UAE?

Choosing the right hospital for stem cell therapy is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include hematology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Stem Cell Therapy

Stem cell therapy is a cutting-edge regenerative medicine procedure that harnesses the body's own biological repair mechanisms — or those of a matched donor — to treat a spectrum of hematological malignancies, autoimmune disorders, and degenerative conditions, achieving disease remission or functional restoration in 60–80% of eligible patients depending on indication and protocol.

21–35 days (inpatient, including conditioning regimen and immediate post-transplant monitoring; autologous procedures may be shorter at 14–21 days)
Hospital Stay
6–12 weeks (fit-to-fly clearance depends on engraftment confirmation, absence of graft-versus-host disease, and stable absolute neutrophil count ≥ 500 cells/µL; allogeneic recipients typically require the longer end of this range)
Total Stay in Country (Fit-to-Fly)
60–80% (disease-free survival at 5 years varies by indication: ~80% for AML in first complete remission, ~65–70% for multiple myeloma post-autologous transplant, ~60% for aplastic anaemia post-allogeneic transplant)
Success Rate

Clinical Overview

  • Stem cell therapy — formally encompassing Haematopoietic Stem Cell Transplantation (HSCT), bone marrow transplantation (BMT), and emerging non-haematopoietic cellular therapies — works by replacing or supplementing a patient's damaged, malignant, or deficient cell populations with healthy progenitor cells capable of self-renewal and multi-lineage differentiation.
  • In haematological cancers such as acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), Hodgkin and non-Hodgkin lymphoma, and multiple myeloma, the diseased bone marrow is first ablated using high-dose chemotherapy (myeloablative conditioning, MAC) or reduced-intensity conditioning (RIC) regimens — commonly BEAM (carmustine, etoposide, cytarabine, melphalan) for lymphomas or Busulfan/Cyclophosphamide for AML — before healthy stem cells are infused intravenously and allowed to engraft within the marrow niches.
  • Beyond oncology, HSCT is an established curative option for non-malignant disorders including severe aplastic anaemia, sickle cell disease, beta-thalassaemia major, severe combined immunodeficiency (SCID), and Hurler syndrome, while mesenchymal stem cell (MSC) therapy is increasingly deployed in graft-versus-host disease (GvHD), Crohn's disease, and certain autoimmune conditions.
Full details →

Who is a Candidate?

  • IDEAL CANDIDATES — HAEMATOLOGICAL MALIGNANCIES:
  • Acute Myeloid Leukaemia (AML) in first or second complete remission (CR1/CR2), particularly intermediate- or high-risk cytogenetics per ELN 2022 classification
  • Acute Lymphoblastic Leukaemia (ALL) in CR1 (high-risk features: Philadelphia chromosome-positive [Ph+], MRD-positive) or CR2
  • Hodgkin Lymphoma relapsed/refractory after ≥2 lines of therapy, eligible for autologous HSCT
  • +29 more

Treatment Options & Approaches

  • AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (Auto-HSCT):

Recovery

  • PHASE 1 — REMOTE PRE-TRANSPLANT EVALUATION (4–8 weeks before travel):

Risks to be aware of

  • Stem cell therapy, particularly allogeneic HSCT, carries a significant risk profile that must be openly discussed with every patient before proceeding.
  • Treatment-related mortality (TRM) — death attributable to the procedure rather than underlying disease — ranges from 5–10% in matched sibling donor transplants at experienced centres to 15–20% in MUD or haploidentical transplants, and is higher in older patients and those with comorbidities, as quantified by the HCT-CI (Haematopoietic Cell Transplantation-specific Comorbidity Index) score.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a fully integrated, end-to-end patient support infrastructure designed specifically for international patients undergoing stem cell therapy in India or the UAE — managing every non-clinical element of the journey so that patients and their families can focus entirely on treatment and recovery.

Common questions about Stem Cell Therapy

What is the cost of Stem Cell Therapy in India versus the UAE?
The cost of stem cell therapy varies significantly by procedure type and destination. In India, the total cost ranges from approximately USD 18,000 to USD 55,000 — covering autologous HSCT (e.g., high-dose melphalan + stem cell rescue for multiple myeloma at the lower end) through full allogeneic matched unrelated donor (MUD) transplants with 30+ days of inpatient isolation (at the higher end). In the UAE (Dubai or Abu Dhabi), equivalent procedures typically cost between USD 40,000 and USD 110,000, reflecting higher facility overheads, luxury infrastructure, and operating costs in the Gulf. By comparison, the same allogeneic transplant in the United States costs USD 250,000–500,000, and in Germany or the UK, USD 120,000–200,000. Both India and the UAE offer JCI-accredited transplant centres with access to international donor registries (DKMS, NMDP), the same conditioning regimens (BuCy, BEAM, RIC fludarabine-based), and equivalent post-transplant monitoring technology. India's cost advantage (typically 40–60% lower than the UAE) makes it the most competitive destination globally for budget-conscious patients who do not compromise on quality. CAR-T cell therapy (e.g., tisagenlecleucel for B-ALL, axicabtagene ciloleucel for DLBCL) is available in both countries and generally costs USD 80,000–130,000 in India and USD 150,000–250,000 in the UAE — still a fraction of US pricing (USD 450,000+). GAF Healthcare provides a fully itemised cost estimate within 72 hours of medical record submission.
How long do I need to stay in the country before I am fit to fly home after stem cell therapy?
This is one of the most critical planning questions for international stem cell therapy patients, and the honest answer is: it is longer than for almost any other procedure. The minimum recommended in-country stay is 6 weeks post-transplant for autologous HSCT recipients (e.g., multiple myeloma or lymphoma patients), provided engraftment is confirmed (ANC > 500/µL on three consecutive days and platelet count > 20,000/µL independently), there is no active infection, and the patient is fully self-managing oral medications. For allogeneic HSCT recipients — including matched sibling, matched unrelated donor, and haploidentical transplants — the standard fit-to-fly window is 8 to 12 weeks post-transplant. This longer period is necessary to ensure stable engraftment is confirmed by STR-PCR chimerism testing, acute GvHD (if present) is controlled to Grade ≤ I on an acceptable oral immunosuppression regimen, CMV viral load is negative or stably suppressed, and the patient has been transitioned safely to an oral prophylactic regimen (tacrolimus or cyclosporine, letermovir, antifungal prophylaxis, acyclovir) that can be continued at home. Long-haul air travel is a particular concern for these patients due to hypoxic cabin air pressure, dehydration, and the risk of infectious exposure in airport environments; physicians at our partner centres issue detailed, personalised fit-to-fly certificates. GAF Healthcare arranges serviced apartment accommodation near the transplant centre for the entire outpatient monitoring phase, with private transport to all clinic appointments, so patients and families are fully supported throughout this period without needing to remain hospitalised.
What is the success rate of Stem Cell Therapy?
Success rates for stem cell therapy vary considerably based on the underlying condition being treated, disease stage at the time of transplant, patient age, performance status, and the type of transplant performed, so it is important to interpret any single figure with clinical context rather than as a universal promise. For the most common indications: Acute Myeloid Leukaemia (AML) in first complete remission (CR1) with favourable or intermediate-risk cytogenetics — 5-year disease-free survival (DFS) of 50–70% with matched sibling donor allogeneic HSCT; 40–60% with matched unrelated donor. AML in CR2 — 35–50% 5-year DFS. Acute Lymphoblastic Leukaemia (ALL) in CR1 (high-risk/Ph+) — 50–65% 5-year DFS; in CR2 — 35–55%. Multiple Myeloma post-autologous HSCT (following modern VRd or Dara-VRd induction) — progression-free survival (PFS) of 50–60% at 5 years; overall survival 70–80% at 5 years with modern maintenance lenalidomide. Hodgkin Lymphoma, autologous HSCT in chemosensitive relapse — 5-year PFS approximately 45–50%; with brentuximab vedotin maintenance, improved to 60–65%. Severe Aplastic Anaemia with matched sibling donor allogeneic HSCT in patients under 40 — overall survival of 80–90% at 5 years, representing a highly curative outcome. Beta-Thalassaemia Major (Pesaro Class I–II) with matched sibling donor — thalassaemia-free survival of 85–90% in young patients at expert centres. CAR-T therapy for relapsed/refractory B-ALL — complete remission rates of 70–90%, though durable remission without consolidative HSCT remains under study. These figures are benchmarked against EBMT registry data and are consistent with outcomes published by JCI-accredited centres in India and the UAE that partner with GAF Healthcare. Your transplant physician will provide personalised prognostic estimates based on your specific disease biology, HLA matching, and pre-transplant disease burden (including MRD status).

Related pages

How GAF Healthcare Assists in Choosing the Best Hospital for Stem Cell Therapy in Dubai, UAE

Discover the Top Hospitals for Stem Cell Therapy in Dubai, UAE

This page lists 3 accredited hematology hospitals in Dubai, UAE, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Patient Success Story

Iraqi Family's Journey: Baby Ibrahim's Life-Saving Heart Surgery in India
Common Questions

Frequently asked questions about stem cell therapy in Dubai, UAE

How many hematology hospitals are listed in Dubai, UAE?
3 hospitals in our Dubai, UAE directory are currently listed for hematology including Stem Cell Therapy.
How do you choose which hospitals to list?
A hospital appears on this page when Hematology is among its listed specialties and it is located in Dubai, UAE. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in UAE?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there hematology hospitals for this in other UAE cities?
See the "Hospitals in other cities" links on this page for the full UAE list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including Hospital Certificates of Services, JCI — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for stem cell therapy?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about stem cell therapy in Dubai, UAE.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for stem cell therapy in Dubai, UAE.

Contact us to report an inaccuracy on this page.

WhatsApp Us